Isis Pharma (ISIS) Receives $6M from AstraZeneca (AZN) in Research Collaboration
Tweet Send to a Friend
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has earned a $6 million payment from AstraZeneca (NYSE: AZN) related to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
